Aia Group LTD United Therapeutics Corp Transaction History

Aia Group LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$212.99 - $276.17 $851,960 - $1.1 Million	4,000 New	4,000 $895,000
Q1 2021 May 14, 2021	SELL	$153.94 - $174.85 $615,760 - $699,400	-4,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$101.87 - $151.79 $407,480 - $607,160	4,000 New	4,000 $680,000

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

Stay updated on Aia Group LTD with notifications on news.